Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
11/2007
11/08/2007WO2007125196A1 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents
11/08/2007US20070259120 Addition compounds as dispersants and dispersion stabilizers
11/08/2007CA2650480A1 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents
11/08/2007CA2649075A1 Tigeycline crystalline forms and processes for preparation thereof
11/07/2007EP1852416A1 Enantiomeric resolution of a carnitinamide salt by preferential crystallization
11/07/2007CN100347162C N-苯基-2-嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative
11/06/2007US7291620 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease
11/01/2007US20070254916 Aryl and heteroaryl compounds, compositions, and methods of use
10/2007
10/31/2007EP1849766A1 Beta-benzyloxyaspartic acid derivative having two substituents on benzene ring
10/31/2007EP1848686A2 9-substituted tetracyclines
10/31/2007EP1848685A1 11a, 12-derivatives of tetracycline compounds
10/31/2007EP1848684A1 Ester-linked gemini surfactant compounds for use in gene therapy
10/31/2007EP1246795B1 Antibacterial agents
10/31/2007EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/31/2007CN100345821C Process for preparation of iopamidol and new intermediates therein
10/30/2007US7288567 Inhibitors of histone deacetylase
10/25/2007WO2007120913A2 Isolation of tetracycline derivatives
10/25/2007WO2007120083A1 The use of carboxamide derivatives in the manufacture of a medicament for the treatment of inflammatory, allergic and dermatological conditions
10/25/2007WO2007077508A3 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
10/25/2007US20070249853 Colorless, photostable, broad UV-A sunscreen agent compounds based on bis(4-aminophenyl)-2-cyanoacrylates) where the amino group on the phenyl forms an amide, carbamate, or sulfonamide in the linking group; also corresponding cyanoacrylamide and 1-cyanovinylsulfones
10/25/2007US20070249719 Compounds for the treatment of metabolic disorders
10/25/2007US20070249696 Compounds for the treatment of metabolic disorders
10/25/2007CA2649221A1 Isolation of tetracycline derivatives
10/24/2007EP1846375A1 2-amino-1-phenylethylcarboxamide derivatives
10/24/2007EP1846366A1 Norvaline derivative and method for preparation thereof
10/24/2007EP1846356A1 Functionalized esters, amides or urethanes of perfluorinated alcohols or amines as surface modifiers
10/24/2007EP1287006B1 Antitumoral compounds
10/24/2007CN101058548A Method for preparing theanine
10/24/2007CN100344616C Compounds for the treatment of metabolic disorders
10/24/2007CN100344609C Improved process for synthesizing ioversol
10/24/2007CN100344607C Process for making theanine and theanine food and drink with high nutrition
10/24/2007CN100344606C Iodine Ioxilan preparation method
10/18/2007WO2007117544A2 Carnitine conjugates of adamantanamines and neramexane derivatives as duel prodrugs for various uses
10/18/2007US20070244335 Isolation of tetracycline derivatives
10/18/2007US20070244172 Compounds for the treatment of metabolic disorders
10/18/2007US20070244171 Compounds for the treatment of metabolic disorders
10/18/2007US20070244141 Compounds for the treatment of metabolic disorders
10/18/2007CA2648668A1 Synthesis of tetracyclines and analogues thereof
10/17/2007CN101056845A Substituted aniline derivatives
10/16/2007US7282608 Inhibitors of histone deacetylase
10/16/2007US7282607 Process for the preparation of iopamidol
10/16/2007US7282605 N-allylcarboxamide derivative undergoes rearrangement reaction diastereoselectively in the presence of a base to give a 2-allylcarboxamide derivative, derivative is subjected to a carbamation reaction and solvolysis to give an optically active 2-allylcarboxylic acid ester, and ester is hydrolyzed
10/11/2007WO2007093539A3 Benzoyl-substituted alanines
10/11/2007WO2007005740A3 Sunless tanning substrate
10/11/2007US20070238783 Beta-benzyloxyaspartate derivatives with amino group on benzene ring
10/11/2007US20070238671 Isopeptide Gap Junction Modulators
10/11/2007US20070237732 Gelling agent for oil
10/11/2007CA2648121A1 Preparation of chiral amides and amines
10/10/2007EP1841728A1 Compounds for treating urinary incontinence
10/10/2007EP1841504A2 Substituted biaryl compounds as factor xia inhibitors
10/09/2007US7279340 Synthesis and application of procainamide analogs for use in an immunoassay
10/04/2007WO2007112121A2 Tetracycline compounds and methods of treatment
10/04/2007WO2007110727A2 Amide stabilized hydroxyethylamines
10/04/2007WO2007079593A8 Novel melatonin ligands having antidepressant activity as well as sleep inducing properties
10/04/2007US20070232699 N-(10,12-pentacosadiynoyl)-N',N'-diethylethylenediamine hydrobromide; amphiphilic diacetylene compounds having a bilayer-compatible hydrophobic chain; acetylenic homopolymers; microbiocides; nanostructures such as nanocarpets; uniform dimensions; biosensors; optics; electronics; drugs
10/04/2007CA2646244A1 Tetracycline compounds and methods of treatment
10/03/2007EP1697300A4 Bone targeting compounds for delivering agents to the bone for interaction therewith
10/03/2007EP1412383B9 Peptide conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri)
10/03/2007CN101045698A Preparation method of ioxaglic alcohol
10/02/2007US7276610 Aryl piperidine amides
10/02/2007US7276534 Carbon-substituted diketopiperazine delivery systems
10/02/2007US7276500 Substituted amides, their preparation and use
09/2007
09/27/2007WO2007109080A2 Deuterated hepatitis c protease inhibitors
09/27/2007WO2007109023A1 Processes and intermediates for preparing steric compounds
09/27/2007WO2007107317A1 Salt of aliskiren with sulfuric acid
09/27/2007US20070225373 Zn2Motif-Tethered Short-Chain Fatty Acids as a Novel Class of Histone Deacetylase
09/27/2007CA2646229A1 Deuterated hepatitis c protease inhibitors
09/27/2007CA2646123A1 Processes and intermediates for preparing steric compounds
09/27/2007CA2643937A1 Salt of aliskiren with sulfuric acid
09/26/2007EP1341753B1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/26/2007CN101044112A O-aminophenol derivatives and colorants containing these compounds
09/26/2007CN101041628A Preparation method for isotopic element marked 15N-L-glutamine
09/26/2007CN101041627A Method for synthesizing for isotopic element marked 15N-L-glutamine
09/26/2007CN101041626A Tetrafluorobenzyl derivatives and pharmaceutical composition containing same
09/26/2007CN100339354C Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation
09/25/2007US7273951 Polyhydroxy phenols and their use in binding p-selectin
09/25/2007US7273863 Benzophenones as inhibitors of reverse transcriptase
09/25/2007CA2256516C Peptides
09/20/2007WO2007105729A1 Process for production of cyclopropylamide compound
09/20/2007WO2007105650A1 4-hydroxyisoleucine derivative and process for producing the derivative
09/20/2007WO2007104959A1 Amino acid derivatives
09/20/2007CA2646256A1 Amino acid derivatives
09/20/2007CA2629348A1 Glucagon receptor antagonists, preparation and therapeutic uses
09/19/2007EP1511719B1 Amide derivatives as inhibitors of the enzymatic activity of renin
09/19/2007CN101037396A Method for reclaiming terramycin from its production mother liquid
09/19/2007CN100338032C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
09/18/2007US7271270 High affinity small molecule C5a receptor modulators
09/13/2007US20070213559 desalting step of removing a salt contained in the aqueous solution and/or formed in the neutralization step, and a step of separately collecting the optically active amino acid amide/amino acid separately from the desalted aqueous solution by a process which takes advantage of a difference in solubility
09/13/2007US20070213379 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
09/13/2007US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/12/2007EP1831153A2 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
09/12/2007EP1831150A1 Process for the preparation of (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionamide and (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionic acid alkyl ester
09/12/2007EP1019358B2 3,3-diarylpropylamines , their use and preparation
09/12/2007CN101033199A Method of recovering terramycin from terramycin production mother liquid
09/12/2007CN100336800C Process for S-N,N'-bis [2-hydroxy-1-(hydroxymethyl)ethyl]-5-[2-hydroxyl-1-oxopropyl)-amino]-2,4,6-triiodo-1,3-benzenedicarboxamide
09/11/2007US7268166 Substituted 4-phenyl amino butane; spinal chord injuries, neuroprotectants, anticonvulsants, anxiolytics, analgesics, muscle relaxants or adjuvants to general anesthetics
09/11/2007US7268147 For therapy of inflammatory, allergic and respiratory diseases
09/11/2007CA2070419C Synthesis and use of amino acid fluorides as peptide coupling reagents
09/07/2007CA2642813A1 Inhibitors of histone deacetylase
09/06/2007US20070208166 Tao Kinase Modulators And Method Of Use
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 162